SCHEMBL15675855

SCHEMBL15675855

CCNCC#CCc1ccccc1C(O)(C(=O)O)C1CCCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
CHRM2 P08172 7/20 0.40
CHRM1 P11229 7/20 0.40
CHRM3 P20309 7/20 0.40
KCNH2 Q12809 3/20 0.40
CYP2C19 P33261 2/20 0.40
SLC6A3 Q01959 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
THPO P40225 1/20 0.40
ABCB11 O95342 1/20 0.40
ESR1 P03372 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
ADRA2A P08913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL717693 0.84 CHRM2 (0.58) KEAP1NFE2L2CHRM2CHRM1CHRM3
SCHEMBL6253388 0.83 KEAP1 (0.46) KEAP1NFE2L2CHRM2CHRM1CHRM3
SCHEMBL27482236 0.79 KEAP1 (0.63) KEAP1NFE2L2CHRM2CHRM1CHRM3
SCHEMBL8573019 0.79 KEAP1 (0.52) KEAP1NFE2L2CHRM2CHRM1CHRM3
SCHEMBL9473847 0.75 KEAP1 (0.54) KEAP1NFE2L2CHRM2CHRM1CHRM3
Hydrochloric Acid SCHEMBL9473542 0.74 KEAP1 (0.52) KEAP1NFE2L2CHRM2CHRM1CHRM3
SCHEMBL8334334 0.73 KEAP1 (0.51) KEAP1NFE2L2CHRM2CHRM1CHRM3
N-Desethyloxybutynin SCHEMBL3395516 0.72 KCNH2 (0.72) KEAP1NFE2L2CHRM2CHRM1CHRM3
N-Desethyloxybutynin SCHEMBL6049998 0.72 KCNH2 (0.72) KEAP1NFE2L2CHRM2CHRM1CHRM3
SCHEMBL2739106 0.72 CHRM2 (0.54) KEAP1NFE2L2CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014078059-A1 METHODS FOR THE TREATMENT OF SIALORRHEA NeuRx Pharmaceuticals LLC (US) 2014-05-22 WO disclosed
US-20140135392-A1 METHODS FOR THE TREATMENT OF SIALORRHEA NeuRx Pharmaceuticals LLC (US) 2014-05-15 US disclosed